No abstract available
MeSH terms
-
Anti-Anxiety Agents / adverse effects
-
Anti-Anxiety Agents / therapeutic use
-
Attention Deficit and Disruptive Behavior Disorders / chemically induced
-
Attention Deficit and Disruptive Behavior Disorders / diagnosis*
-
Attention Deficit and Disruptive Behavior Disorders / psychology
-
Child
-
Comorbidity
-
Diagnosis, Differential
-
Dose-Response Relationship, Drug
-
Down Syndrome / diagnosis*
-
Down Syndrome / psychology
-
Heart Defects, Congenital / diagnosis
-
Heart Defects, Congenital / psychology
-
Hospitalization
-
Humans
-
Hypertension, Pulmonary / diagnosis
-
Hypertension, Pulmonary / drug therapy
-
Hypertension, Pulmonary / psychology
-
Lorazepam / adverse effects
-
Lorazepam / therapeutic use
-
Male
-
Oxygen Inhalation Therapy
-
Piperazines / adverse effects
-
Piperazines / therapeutic use
-
Pulmonary Disease, Chronic Obstructive / diagnosis
-
Pulmonary Disease, Chronic Obstructive / psychology
-
Purines / adverse effects
-
Purines / therapeutic use
-
Risk Factors
-
Sildenafil Citrate
-
Sulfones / adverse effects
-
Sulfones / therapeutic use
-
Vasodilator Agents / adverse effects
-
Vasodilator Agents / therapeutic use
Substances
-
Anti-Anxiety Agents
-
Piperazines
-
Purines
-
Sulfones
-
Vasodilator Agents
-
Sildenafil Citrate
-
Lorazepam